Document is current
Any future updates will be listed below
-
Authors
Koopman, Werner JH
Beyrath, Julien
Fung, Cheuk‐Wing
Koene, Saskia
Rodenburg, Richard J
Willems, Peter HGM
Smeitink, Jan AM
-
Funding
Funding for this research was provided by:
The Netherlands Organization for Health Research and Development‐Medical Sciences (40‐41900‐98‐033)
Stichting Energy4All
CSBR
The Netherlands Organisation for Scientific Research (CSBR09/013V)
- License Information
-
More Information
Article History
Received: 7 December 2015
Revised: 5 February 2016
Accepted: 11 February 2016
First Online: 8 March 2016
Conflict of interest
: JAMS is the founding CEO of Khondrion ( ), a Radboud University Medical Center spin‐off biotech company. JB is the COO, and PHGMW and WJHK are scientific consultants of this company.
